Joint source of Boehringer Ingelheim GmbH and Pfizer Inc
Data From Largest GOLD Stage II Patient Population Treated With Tiotropium Highlight the Benefits of Earlier Treatment of COPD
Ingelheim, Germany (ots/PRNewswire) - - New UPLIFT(R) Analysis Shows Tiotropium Significantly Improves Lung Function and Quality of Life in COPD Patients With Early Stage Disease - Not for US Media A new analysis of the landmark UPLIFT(R) trial, published today in the Lancet, shows that tiotropium ...